Conecte-se

Bibliografias temáticas / Bone resorption / Livros

Siga este link para ver outros tipos de publicações sobre o tema: Bone resorption.

Livros sobre o tema "Bone resorption"

Autor: Grafiati

Publicado: 4 de junho de 2021

Última modificação: 1 de agosto de 2024

Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos

Selecione um tipo de fonte:

Veja os 50 melhores livros para estudos sobre o assunto "Bone resorption".

Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.

Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.

Veja os livros das mais diversas áreas científicas e compile uma bibliografia correta.

1

Bronner, Felix, Mary C. Farach-Carson e Janet Rubin, eds. Bone Resorption. London: Springer-Verlag, 2005. http://dx.doi.org/10.1007/b136184.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

2

Felix, Bronner, Farach-Carson Mary C. 1958- e Rubin Janet, eds. Bone resorption. London: Springer, 2005.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

3

Harvey, Wilson. Prostaglandins in bone resorption. Boca Raton, Fla: CRC Press, 1988.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

4

Pierce, Angela Mary. Cellular mechanisms in bone and tooth resorption: Morphological studies in rats and monkeys. Stockholm: Kongl. Carolinska Medico Chirurgiska Institutet, 1988.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

5

Brown, R. James. Histological and compositional responses of bone to immobilization and other experimental conditions: Semi-annual report. San Francisco, Calif: Institute of Chemical Biology, University of San Francisco, 1985.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

6

Thamsborg, Gorm. Effect of nasal salmon calcitonin on calcium and bone metabolism. København [Denmark]: Lægeforeningens Forlag, 1999.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

7

Maria, Bijvoet Olav Leonardus, ed. Bisphosphonate on bones. Amsterdam: Elsevier, 1995.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

8

Arun, Shanbhag, Rubash Harry E e Jacobs Joshua J. 1956-, eds. Joint replacement and bone resorption: Pathology, biomaterials, and clinical practice. New York: Taylor & Francis, 2005.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

9

Åkesson, Louise. Panoramic radiography in the assessment of the marginal bone level. Malmö: Department of Oral Radiology, Faculty of Odontology, Lund University, 1991.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

10

Ljunggren, Östen. Experimental studies on bone resorption: Effects of parathyroid hormone and vitamin D. Uppsala: Univ., 1993.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

11

Fleisch, Herbert. Bisphosphonates in bone disease: From the laboratory to the patient. Bern: H. Fleish, 1993.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

12

Ransjö, Maria. Regulation of bone resorption by the adenylate cyclase-cyclic AMP system: A biochemical study on mouse calvarial bones and isolated bone cells. Umeå, Sweden: University of Umeå, 1988.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

13

Loomer, Peter Michael. The direct effects of Porphyromonas Gingivalis 2561 on bone formation and mineral resorption in vitro. [Toronto: University of Toronto, Faculty of Dentistry], 1997.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

14

D, Rubens R., e European Conference on Clinical Oncology (5th : 1989 : London, England), eds. The Management of bone metastases and hypercalcaemia by osteoclast inhibition: An international symposium held during the 5th European Conference on Clinical Oncology (ECCO 5), London, September 1989. Toronto: Hogrefe & Huber, 1990.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

15

Karhukorpi, Eeva-Kaisa. The mode of action of osteoclasts in bone resorption: An ultrastructural study of enzymes possibly involved. Oulu: University of Oulu], Department of Anatomy, 1991.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

16

Clemens Waltherus Gerardus Maria Löwik. The mechanism of action of parathyroid hormone in bone resorption: The role of intracellular calcium and cAMP. [s.l.]: [s.n.], 1987.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

17

Congress, European Society for Medical Oncology. Disodium pamidronate (APD) in the treatment of malignancy-related disorders: An international symposium held during the 13th Congress of the European Society for Medical Oncology (ESMO), Lugano, Switzerland, October 1988. Toronto: Hogrefe & Huber, 1990.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

18

Meyer, James L. I loved a boy: Confessions of a Roman Catholic priest. Royal Oak, Mich: Van Antwerp and Beale Publishers, 2007.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

19

Meyer, James L. I loved a boy: Confessions of a Roman Catholic priest. Royal Oak, Mich: Van Antwerp and Beale Publishers, 2007.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

20

Peter, Burckhardt, ed. Disodium pamidronate (APD) in the treatment of malignancy-related disorders. Toronto: Huber, 1989.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

21

Shorey, Seema. Differences in the degree to which osteoclasts from different parts of the skeleton employ cathepsin K and matrix metalloproteinases for bone resorption. Ottawa: National Library of Canada, 2002.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

22

Tai, Victoria. The effects of leukotriene Bb4s on osteoclast formation and osteoclastic bone resorption and the role of osteoblastic cells in these processes. Ottawa: National Library of Canada = Bibliothèque nationale du Canada, 1999.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

23

Mundy, Gregory R. Bone remodeling and its disorders. London: Martin Dunitz, 1994.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

24

Bronner, Felix, Janet Rubin e Mary C. Farach-Carson. Bone Resorption. Springer London, Limited, 2006.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

25

Bronner, Felix, Janet Rubin e Mary C. Farach-Carson. Bone Resorption. Springer London, Limited, 2010.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

26

Harvey, Wilson, e Alan Bennett. Prostaglandins in Bone Resorption. CRC Press, 2020. http://dx.doi.org/10.1201/9780429279195.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

27

Harvey, Wilson, e Alan Bennett. Prostaglandins in Bone Resorption. Taylor & Francis Group, 2020.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

28

Prostaglandins in Bone Resorption. Taylor & Francis Group, 2020.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

29

Harvey, Wilson, e Alan Bennett. Prostaglandins in Bone Resorption. Taylor & Francis Group, 2020.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

30

Harvey, Wilson, e Alan Bennett. Prostaglandins in Bone Resorption. Taylor & Francis Group, 2020.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

31

Harvey, Wilson, e Alan Bennett. Prostaglandins in Bone Resorption. Taylor & Francis Group, 2019.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

32

Osteoblasts: Morphology, Functions and Clinical Implications. Nova Science Pub Inc, 2013.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

33

Shanbhag, Arun, Harry E. Rubash e Joshua J. Jacobs, eds. Joint Replacement and Bone Resorption. CRC Press, 2005. http://dx.doi.org/10.1201/b14138.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

34

Rubash, Harry E., Arun Shanbhag e Joshua J. Jacobs. Joint Replacement and Bone Resorption. Taylor & Francis Group, 2019.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

35

Bone resorption, metastasis, and diphosphonates. New York: Raven Press, 1985.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

36

(Editor), Kurt W. Brunner, Herbert Fleisch (Editor) e Hans-Jörg Senn (Editor), eds. Bisphosphonates and Tumor-Osteolysis (Recent Results in Cancer Research). Springer, 1995.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

37

Anderson, Paul, Borje Edgar Christopher Nordin e Howard Arthur Morris. Physiological Basis of Metabolic Bone Disease. Taylor & Francis Group, 2014.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

38

Anderson, Paul, Borje Edgar Christopher Nordin e Howard Arthur Morris. Physiological Basis of Metabolic Bone Disease. Taylor & Francis Group, 2014.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

39

Anderson, Paul. Physiological Basis of Metabolic Bone Disease. Taylor & Francis Group, 2014.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

40

Anderson, Paul. Physiological Basis of Metabolic Bone Disease. Taylor & Francis Group, 2017.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

41

Rubash, Harry E., Arun Shanbhag e Joshua J. Jacobs. Joint Replacement and Bone Resorption: Pathology, Biomaterials and Clinical Practice. Taylor & Francis Group, 2005.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

42

(Editor), Arun Shanbhag, Harry E. Rubash (Editor) e Joshua J. Jacobs (Editor), eds. Joint Replacement and Bone Resorption: Pathology, Biomaterials and Clinical Practice. Informa Healthcare, 2005.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

43

Rubash, Harry E., Arun Shanbhag e Joshua J. Jacobs. Joint Replacement and Bone Resorption: Pathology, Biomaterials and Clinical Practice. Taylor & Francis Group, 2005.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

44

Mansfield, Ian David. The synthesis of novel agents which inhibit tumour-stimulated bone resorption. 1999.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

45

The relationship between bone mineral density and selected variables: An epidemiological perspective. 1990.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

46

Javaid, Kassim. Paget’s disease of bone. Editado por Patrick Davey e David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0274.

Texto completo da fonte

Resumo:

Paget’s disease of bone is an uncommon bone disorder with increased bone resorption and disorganized bone formation of woven bone. Its cause is unclear; there is a clear genetic component but additional environmental factors are important, given the reduction in severity and prevalence in the UK. Paget’s disease is usually asymptomatic and detected by an unexplained raised alkaline phosphatase on routine biochemistry. Symptoms include focal bone pain, including headache. Other symptoms include bone deformity and complications such as fracture and nerve conduction. Paget’s disease can sometimes present with immobilization-associated hypercalcaemia or high-output cardiac failure, and rarely can transform to an osteosarcoma. This chapter addresses the clinical features, diagnosis, and management of Paget’s disease of bone.

Estilos ABNT, Harvard, Vancouver, APA, etc.

47

Wordsworth, B. P. Skeletal dysplasias. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199642489.003.0150.

Texto completo da fonte

Resumo:

Bone is metabolically active throughout life and metabolic disturbances may have wide-ranging consequences that are not restricted to altering its mechanics. The study of some genetic bone diseases has already provided remarkable insights into the normal regulation of bone metabolism. Skeletal dysplasias are developmental disorders of the chondro-osseous tissues commonly resulting in short stature, which is often disproportionate. The underlying mutations are often in the structural genes encoding components of the matrix but may also involve growth factors or cell signalling. In contrast, the dysostoses tend to affect single bones or groups of bones, reflecting the transient nature of the many different signalling factors to which they are responsive during development. Abnormalities of bone density (high or low) may be due to primary deficiency of bone matrix synthesis (e.g. osteogenesis imperfecta and hypophosphatasia) but may also reflect an imbalance between bone formation and resorption. This may be caused by abnormalities of bone formation (e.g. hyperostosis/sclerosteosis and osteoporosis pseudoglioma syndrome) or bone resorption (e.g. classic osteopetrosis and fibrous dysplasia).

Estilos ABNT, Harvard, Vancouver, APA, etc.

48

Ralston, Stuart H. Paget’s disease of bone. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199642489.003.0144.

Texto completo da fonte

Resumo:

Paget's disease of bone (PDB) affects up to 1% of people of European origin aged 55 years and above. It is characterized by focal abnormalities of bone remodelling which disrupt normal bone architecture, leading to expansion and reduced mechanical strength of affected bones. This can lead to various complications including deformity, fracture, nerve compression syndromes, and osteoarthritis, although many patients are asymptomatic. Genetic factors play a key role in the pathogenesis of PDB. This seems to be mediated by a combination of rare genetic variants which cause familial forms of the disease and common variants which increase susceptibility to environmental triggers. Environmental factors which have been suggested to predispose to PDB include viral infections, calcium and vitamin D deficiency, and excessive mechanical loading of affected bones. The diagnosis can be made by the characteristic changes seen on radiographs, but isotope bone scans are helpful in defining disease extent. Serum alkaline phosphatase levels can be used as a measure of disease activity. Inhibitors of bone resorption are the mainstay of medical management for PDB and bisphosphonates are regarded as the treatment of choice. Bisphosphonates are highly effective at reducing bone turnover in PDB and have been found to heal osteolytic lesions, and normalize bone histology. Although bisphosphonates can improving bone pain caused by elevated bone turnover, most patients require additional therapy to deal with symptoms associated with disease complications. It is currently unclear whether bisphosphonate therapy is effective at preventing complications of PDB.

Estilos ABNT, Harvard, Vancouver, APA, etc.

49

Ralston, Stuart H. Paget’s disease of bone. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199642489.003.0144_update_001.

Texto completo da fonte

Resumo:

Paget’s disease of bone (PDB) affects up to 1% of people of European origin aged 55 years and above. It is characterized by focal abnormalities of bone remodelling which disrupt normal bone architecture, leading to expansion and reduced mechanical strength of affected bones. This can lead to various complications including deformity, fracture, nerve compression syndromes, and osteoarthritis, although many patients are asymptomatic. Genetic factors play a key role in the pathogenesis of PDB. This seems to be mediated by a combination of rare genetic variants which cause familial forms of the disease and common variants which increase susceptibility to environmental triggers. Environmental factors which have been suggested to predispose to PDB include viral infections, calcium and vitamin D deficiency, and excessive mechanical loading of affected bones. The diagnosis can be made by the characteristic changes seen on radiographs, but isotope bone scans are helpful in defining disease extent. Serum alkaline phosphatase levels can be used as a measure of disease activity. Inhibitors of bone resorption are the mainstay of medical management for PDB and bisphosphonates are regarded as the treatment of choice. Bisphosphonates are highly effective at reducing bone turnover in PDB and have been found to heal osteolytic lesions, and normalize bone histology. Although bisphosphonates can improving bone pain caused by elevated bone turnover, most patients require additional therapy to deal with symptoms associated with disease complications. It is currently unclear whether bisphosphonate therapy is effective at preventing complications of PDB.

Estilos ABNT, Harvard, Vancouver, APA, etc.

50

Wheeler, Donna L. The short- and long-term effects of methotrexate on the rat skeleton. 1993.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

Oferecemos descontos em todos os planos premium para autores cujas obras estão incluídas em seleções literárias temáticas. Contate-nos para obter um código promocional único!